KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $9,000 | 0.0% | 1,438 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | -62.5% | 1,438 | -45.6% | 0.00% | -100.0% |
| Q1 2019 | $24,000 | 0.0% | 2,645 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $24,000 | -45.5% | 2,645 | +1.8% | 0.00% | -66.7% |
| Q3 2018 | $44,000 | -2.2% | 2,597 | -2.7% | 0.00% | -40.0% |
| Q2 2018 | $45,000 | -4.3% | 2,670 | -23.5% | 0.01% | – |
| Q1 2018 | $47,000 | +422.2% | 3,490 | +262.8% | 0.00% | -100.0% |
| Q4 2017 | $9,000 | -69.0% | 962 | +14.1% | 0.00% | -50.0% |
| Q3 2017 | $29,000 | +11.5% | 843 | -70.9% | 0.00% | -33.3% |
| Q2 2017 | $26,000 | +550.0% | 2,901 | +900.3% | 0.00% | – |
| Q1 2017 | $4,000 | – | 290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |